Adam Walker’s Pharma Prescribed Podcast

Adam Walker’s Pharma Prescribed Podcast

By Adam WalkerBusinessScienceManagementLife Sciences
Download on the App Store

Adam Walker’s Pharma Prescribed Podcast episodes

  • Treat People Like Athletes, Not Assets: The CRO Built on Wellbeing

    Leigh Fell on Caritas Bioscience, Corporate Athleticism & Wellbeing Isn't a Perk | Pharma Prescribed

    Leigh Fell — founder of Caritas Bioscience, Sunday Times 25 Women Succeeding in 2025 and champion of corporate athleticism — joins Adam Walker for a conversation about building a purpose-driven CRO, burnout, wellbeing and what it means to treat people the way you'd want to be treated.

    Leigh started in clinical operations running oncology trials, experienced burnout as a CRA, and vowed to build a company that looked after its people. In 2017 she founded Caritas — named after the Latin motto of both her and Adam's schools meaning love for all. The company now specialises in neurology and oncology trials, has achieved 30% better employee retention through its wellbeing-first culture, and partners with pharma innovators in areas of profound unmet need.

    🎧 LISTEN ON YOUR PREFERRED APP

    Spotify → https://open.spotify.com/episode/7vUuR5kNdUOBfb47OEIcBW?si=QPE0V-VpSvWW3RQ-WSVjrg
    Apple Podcasts → https://podcasts.apple.com/gb/podcast/pharma-prescribed-with-leigh-fell-ceo-of/id1829715970?i=1000722267719
    Amazon Music → https://music.amazon.com/podcasts/1a43eb87-b83e-441d-9a87-321263e3f821/adam-walker%E2%80%99s-pharma-prescribed-podcast
    Podbean → https://pharmaprescribed.podbean.com/

    📖 WHAT WE COVER

    - Burnout as a CRA — and the vow to build a company that looks after people
    - Caritas: ex corde caritas — love from the heart
    - GW Pharma, cannabinoids and paediatric epilepsy — the project that shaped the mission
    - Every illness in her family was neurological: epilepsy, Alzheimer's, stroke, depression
    - Corporate athleticism: treating employees like athletes, not assets
    - 30% better employee retention through wellbeing-first culture
    - Gratitude sessions at the start of every team call
    - Sunday Times 25 Women Succeeding in 2025
    - Bringing oncology lessons into neurology trials
    - AI and the next generation: who teaches the juniors when bots do the groundwork?
    - Do what you love rather than what seems sensible
    - Treat others the way you'd want to be treated — the golden rule

    ⏱️ CHAPTERS

    0:00 Introduction & podcast mission
    1:00 Meet Leigh Fell — founder of Caritas Bioscience
    2:00 Physiology, sports science and nutrition at Glasgow
    3:00 Falling into clinical research and starting in data management
    4:00 Burnout as a CRA — the original why
    5:00 Founding Caritas in 2017: love for all
    6:00 GW Pharma and the family connection to neurology
    8:00 Oncology to neurology to all therapeutic areas
    10:00 Corporate athleticism and employee wellbeing
    12:00 Gratitude sessions, aerial yoga and team bonding
    14:00 30% better retention — what wellbeing culture delivers
    16:00 Sunday Times feature and what recognition means
    18:00 Adapting through pandemic, market shifts and growth
    20:00 Oncology lessons applied to neurology
    24:00 AI in clinical operations — who trains the next generation?
    28:00 The consultant-to-founder transition
    30:00 Quick-fire: do what you love, not what seems sensible
    32:00 Kindness, initiative and enthusiasm in hiring
    33:00 Gun dog training, drawing and walks in the hills
    34:00 Golden rule: treat others how you'd want to be treated

    👤 ABOUT LEIGH FELL

    Founder of Caritas Bioscience. Sunday Times 25 Women Succeeding in 2025. 17 years in clinical development. Neurology and oncology specialist CRO.
    🌐 https://www.caritasbioscience.com
    💼 Search "Leigh Fell" on LinkedIn

    🎙️ ABOUT PHARMA PRESCRIBED

    Long-form conversations with leaders in clinical research, digital health and mental wellbeing, hosted by Adam Walker.
    🌐 https://pharmaprescribed.com
    💼 https://www.linkedin.com/in/adam-walker-2327951/

    #LeighFell #CaritasBioscience #ClinicalOperations #Wellbeing #PharmaPrescribed #AdamWalker #CorporateAthleticism #SundayTimes #WomenInLeadership #CRA #Neurology #Oncology #LifeSciences #ClinicalResearch #FemaleFounder

    35 min
  • Almost Everyone in This Industry Arrived by Accident. Here's What Keeps Them

    Anders Mortin on Triticon, Knowledge World & 25 Years of Accidental Pharma | Pharma Prescribed

    Anders Mortin — co-founder of Triticon and builder of the Knowledge World platform — joins Adam Walker for a conversation about eClinical consulting, knowledge sharing and what it means to build a company that values being useful over being big.

    Anders holds a Master's in engineering physics from Lund University and fell into clinical data management by accident — a handball teammate needed extra hands for data entry at a small CRO. A brief escape to laser optics ended when the company collapsed after 26 days. He went back to pharma and never left. Twenty-five years later, he and his partners run Triticon from a hospital in Copenhagen with meeting rooms themed as a hunting cabin, Bali and Nasa.

    🎧 LISTEN ON YOUR PREFERRED APP

    Spotify → https://open.spotify.com/episode/2OET5ah95hOOM826LcWOfx?si=LeZPBjYuS4iGv5r-OCbbkQ
    Apple Podcasts → https://podcasts.apple.com/gb/podcast/pharma-prescribed-with-anders-mortin-co-founder/id1829715970?i=1000721650878
    Amazon Music → https://music.amazon.com/podcasts/1a43eb87-b83e-441d-9a87-321263e3f821/adam-walker%E2%80%99s-pharma-prescribed-podcast
    Podbean → https://www.podbean.com/eas/pb-x9giy-192fff8

    📖 WHAT WE COVER

    - Handball, data entry and the accidental career in pharma
    - 26 days in laser optics before the company collapsed
    - Building Triticon: eClinical consulting from Copenhagen
    - Knowledge World: a platform for sharing operational knowledge across pharma
    - Why most people in biometrics ended up here by accident
    - The hunting cabin meeting room and Danish work culture
    - CrossFit, garden sheds and doing something tangible with your hands
    - Be of value — the golden rule

    ⏱️ CHAPTERS

    0:00 Introduction & podcast mission
    1:00 Meet Anders Mortin — co-founder of Triticon
    2:00 The hunting cabin meeting room in a Copenhagen hospital
    3:00 Handball, data entry and slipping into pharma by accident
    4:00 26 days in laser optics — and the company that collapsed
    6:00 Paper CRFs, handwritten queries and the old days
    8:00 Building Tricon in Copenhagen with his partners
    10:00 Knowledge World: the platform for operational knowledge sharing
    14:00 Why pharma needs better knowledge transfer
    18:00 Pioneers, feedback and building in public
    22:00 AI, LLMs and what changes for eClinical consulting
    28:00 The consultant's dilemma: automation vs billable hours
    34:00 Mentors and the balance between nerd and communicator
    38:00 Quick-fire: family first, CrossFit, nature and garden sheds
    44:00 Golden rule: be of value — and the tangible life
    46:00 triticon.com, Knowledge World and closing thanks

    👤 ABOUT ANDERS MORTIN

    Co-founder of Triticon, a Copenhagen-based eClinical consultancy. Builder of Knowledge World. Master's in engineering physics. 25+ years in clinical data management.
    🌐 https://www.tricon.com
    💼 Search "Anders Mortin" on LinkedIn

    🎙️ ABOUT PHARMA PRESCRIBED

    Long-form conversations with leaders in clinical research, digital health and mental wellbeing, hosted by Adam Walker.
    🌐 https://pharmaprescribed.com
    💼 https://www.linkedin.com/in/adam-walker-2327951/

    #AndersMortin #Triticon #KnowledgeWorld #eClinical #PharmaPrescribed #AdamWalker #ClinicalDataManagement #Copenhagen #LifeSciences #ClinicalResearch #PharmaConsulting #DanishPharma #KnowledgeSharing #CrossFit #EngineeringPhysics

    48 min
  • The 'Digital Twin' That Tests Your Drug Before Any Patient Does

    Belma Alispahic on SimCell, Digital Twins for Bioprocessing & Why AI Isn't Optional Anymore | Pharma Prescribed

    Belma Alispahic — co-founder and Chief Scientific Officer of Analysismode — joins Adam Walker for a conversation about AI-powered bioprocess development, digital twins and what happens when a curious kid from Bosnia decides she can't be an astronaut.

    Belma has a Master's in applied biotechnology from Uppsala University and co-founded Analysismode during COVID. The company's platform, SimCell, uses AI and digital twins to simulate bioprocesses — helping pharma reduce manufacturing costs, shorten time to market and make smarter development decisions without running every experiment in the lab.

    She recently spoke at the 9th Bioproduction Congress in France. Her message: AI isn't optional — it's essential.

    🎧 LISTEN ON YOUR PREFERRED APP

    Spotify →https://open.spotify.com/episode/3gOM0ul9a0LCim6N734VOi?si=dWoW0w28TkaMtiLdlHeWXg
    Apple Podcasts → https://podcasts.apple.com/gb/podcast/pharma-prescribed-podcast-with-belma-alispahic-ceo/id1829715970?i=1000720744446
    Amazon Music → https://music.amazon.com/podcasts/1a43eb87-b83e-441d-9a87-321263e3f821/adam-walker%E2%80%99s-pharma-prescribed-podcast
    Podbean → https://www.podbean.com/eas/pb-uc9ru-19261e7

    📖 WHAT WE COVER

    - From curious kid in Bosnia to biotech co-founder in Sweden
    - Astronaut, pianist or biologist — the career shortlist
    - SimCell: digital twins for bioprocess development
    - Why therapies cost too much — and how AI reduces manufacturing cost
    - ChatGPT as the inflection point: when AI went from niche to everywhere
    - AI won't replace pharma scientists — but it will change how they work
    - Paper notebooks, Excel sheets and the data lake problem
    - Big pharma hiring AI teams massively — what that means for startups
    - Conservative industry vs the speed of AI adoption
    - Bioproduction Congress in France: AI isn't optional
    - Be honest, be weird — the golden rule

    ⏱️ CHAPTERS

    0:00 Introduction & podcast mission
    1:00 Meet Belma Alispahic — CSO of Analysismode
    2:00 Bosnia, curiosity and the astronaut dream
    3:00 Biology as the closest thing to space
    4:00 Co-founding Analysismode during COVID
    5:00 SimCell: digital twins for bioprocesses
    7:00 Why therapies cost too much
    9:00 ChatGPT as the inflection point for pharma AI
    11:00 Big pharma hiring AI teams massively
    13:00 Paper notebooks, Excel and pharma's data problem
    15:00 AI augmenting not replacing scientists
    18:00 Bioprocessing industry: niche but critical
    20:00 Bioproduction Congress in France
    22:00 How SimCell works: dashboards not code
    25:00 Conservative industry vs AI speed
    28:00 Being a startup in a regulated world
    30:00 The Balkans, accountability and growing up fast
    32:00 Quick-fire: curiosity, integrity, ownership and empathy
    34:00 Music, piano and touching grass after remote work
    36:00 Golden rule: be honest, be weird — take up space

    👤 ABOUT BELMA ALISPAHIC

    Co-founder and CSO of Analysismode. Master's in applied biotechnology (Uppsala University). Builder of SimCell. Speaker at the 9th Bioproduction Congress.
    🌐 https://www.analysismode.com
    💼 Search "Belma Alispahic" on LinkedIn

    🎙️ ABOUT PHARMA PRESCRIBED

    Long-form conversations with leaders in clinical research, digital health and mental wellbeing, hosted by Adam Walker.
    🌐 https://pharmaprescribed.com
    💼 https://www.linkedin.com/in/adam-walker-2327951/

    #BelmaAlispahic #Analysismode #SimCell #DigitalTwins #Bioprocessing #PharmaPrescribed #AdamWalker #AIinPharma #Biotech #BioprocessDevelopment #Uppsala #Bosnia #FemaleFounder #DeepTech #BioproductionCongress

    40 min
  • The Trial That Failed His Mother — So He Rebuilt the System

    Wessam Sonbol on Delve Health & Why Clinical Trials Failed His Mother | Pharma Prescribed

    Wessam Sonbol — founder and CEO of Delve Health — joins Adam Walker for a conversation about decentralised trials, patient concierge teams and what happens when clinical research failed your mother and you decide to fix it.

    Wessam's mom was a cancer patient who struggled to join a clinical trial — not because the science failed, but because the process did. The paperwork, the jargon, the drives, the system. That became the founding story of Delve Health — a platform supporting decentralised and hybrid clinical trials in 65+ languages, with wearables, televisits, AI-powered tools and a concierge team that speaks to 1,500–2,000 patients a week.

    30% reduction in dropout. 20% faster trial completion. 40+ people across US, Belize, Egypt and Pakistan.

    🎧 LISTEN ON YOUR PREFERRED APP

    Spotify → https://open.spotify.com/episode/61S4aebMQMjWsEZYRqUo0N?si=Ae5VOQkrQ4KqDxHvWgO7rw
    Apple Podcasts → https://podcasts.apple.com/gb/podcast/pharma-prescribed-with-wessam-sonbol-ceo-of-delve/id1829715970?i=1000719799789
    Amazon Music → https://music.amazon.com/podcasts/1a43eb87-b83e-441d-9a87-321263e3f821/adam-walker%E2%80%99s-pharma-prescribed-podcast
    Podbean → https://www.podbean.com/eas/pb-xqmxt-191c857

    📖 WHAT WE COVER

    - His mother's cancer and the system that failed her — the founding story
    - 1,500–2,000 patients spoken to every week by the concierge team
    - 65+ languages supported on one platform
    - 30% dropout reduction and 20% faster completion
    - Why pushing out another ePRO diary is not the answer
    - tctmd.com, global registries and the early career by accident
    - Clinical Systems Consultants: scaling across three continents
    - Perter.io: AI and NLP cutting research time by 40%
    - Wearables, televisits and the true meaning of decentralised
    - Oncology and Alzheimer's: the hardest trials to retain patients in
    - Real world evidence and where the future of data is heading
    - The hustle as a golden rule — and why it beats being the smartest

    ⏱️ CHAPTERS

    0:00 Introduction & podcast mission
    1:00 Meet Wessam Sonbol — founder of Delve Health
    3:00 His mother's cancer and the process that failed her
    4:00 Founding Delve Health: making trials accessible
    5:00 Early career by accident: EMR data and cardiovascular marketing
    6:00 tctmd.com and the global registry platform
    8:00 Patient concierge: 1,500–2,000 patients spoken to every week
    10:00 Why another diary or PRO isn't the final answer
    12:00 65+ languages and true global accessibility
    14:00 30% dropout reduction and 20% faster completion
    16:00 Wearables, televisits and AI-powered tools
    18:00 Oncology and Alzheimer's: the hardest trials for retention
    20:00 Clinical Systems Consultants and scaling across three continents
    22:00 Perter.io: AI and NLP for research intelligence
    24:00 40+ people across US, Belize, Egypt and Pakistan
    26:00 Delve as outcomes delivery, not just a platform
    28:00 The future: real world evidence and big data sets
    32:00 Quick-fire: don't stress — it will be okay
    34:00 Persistence, the hustle, stay hungry and stay humble
    36:00 Hanging out with the kids
    37:00 Golden rule: the hustle — go after what you want
    38:00 delvehealth.com and closing thanks

    👤 ABOUT WESSAM SONBOL

    Founder and CEO of Delve Health. 25+ years in clinical research and healthcare technology. Founder of Clinical Systems Consultants. Co-developer of Perter.io.
    🌐 https://www.delvehealth.com
    💼 Search "Wessam Sonbol" on LinkedIn

    🎙️ ABOUT PHARMA PRESCRIBED

    Long-form conversations with leaders in clinical research, digital health and mental wellbeing, hosted by Adam Walker.
    🌐 https://pharmaprescribed.com
    💼 https://www.linkedin.com/in/adam-walker-2327951/

    #WessamSonbol #DelveHealth #DecentralisedTrials #DCT #PharmaPrescribed #AdamWalker #PatientCentric #ClinicalTrials #HealthTech #Wearables #Televisit #AIinPharma #ClinicalResearch #LifeSciences #PatientRetention

    38 min
  • The Missing Metric That Explains Why So Many Treatments Fail

    Philip Morisky on Medication Adherence & Why Healthcare's Metrics Must Be Fixed | Pharma Prescribed

    Philip Morisky — Chief Optimist at Adherence and guardian of the Morisky Medication Adherence Scale (MMAS) — joins Adam Walker for the very first episode of the Pharma Prescribed Podcast.

    Philip's father, Dr. Donald Morisky, developed the MMAS at UCLA over a 40-year career in behavioral science. The scale is now used in over 100 countries and hundreds of languages. Philip has taken it from academic tool to global health technology — building Atlas (a real-time adherence mapping platform), Zoe (an AI conversational agent), and a pharmacist training programme called Expert.

    His title isn't CEO. It's Chief Optimist. Optimist is Latin for the best.

    🎧 LISTEN ON YOUR PREFERRED APP

    Spotify → https://open.spotify.com/search/Philip+Morisky+pharma+prescribed/episodes ⚠️ SWAP
    Apple Podcasts → https://podcasts.apple.com/us/podcast/pharma-prescribed-podcast-with-philip-morisky-chief/id1829715970?i=1000719645833
    Amazon Music → https://music.amazon.com/podcasts/1a43eb87-b83e-441d-9a87-321263e3f821/adam-walker%E2%80%99s-pharma-prescribed-podcast
    Podbean → https://www.podbean.com/eas/pb-6c6h6-191abf8

    📖 WHAT WE COVER

    - What the MMAS is and why it's the gold standard in adherence measurement
    - "Do you sometimes forget?" — how rephrasing one question changes everything
    - Why pharmacy refill data is a disservice to actual medication-taking behaviour
    - Social desirability bias and recall bias: the two reasons most adherence surveys fail
    - Atlas: real-time adherence mapping across countries and demographics
    - Zoe: an AI agent that has a conversation, not a checklist
    - From clinical trials to standard of care — Philip's biggest ambition
    - The Kingdom of Bhutan: integrating MMAS into the Ministry of Health
    - 300+ university collaborations and a library of behavioural science derivatives
    - Smoking cessation, alcohol, exercise and diet: MMAS beyond medication
    - "Mess up early and often" — advice to a younger self
    - Chief Optimist: why the title matters

    ⏱️ CHAPTERS

    0:00 Welcome to the first ever Pharma Prescribed episode
    1:00 Meet Philip Morisky — Chief Optimist at Adherence
    2:00 His father Dr. Donald Morisky and 40 years at UCLA
    3:00 The kid who always asked why — and built a career around it
    4:00 Why patients don't adhere: it's not the science, it's the silence
    5:00 "Do you sometimes forget?" — rephrasing the question
    6:00 Social desirability bias and the truth behind patient responses
    7:00 Paper diaries vs ePRO — what we now know about honesty
    8:00 Using MMAS in clinical trials: protocols, CROs and sponsors
    9:00 Global reach: translations into hundreds of languages and dialects
    10:00 Atlas: real-time adherence data mapped across the world
    11:00 From benchmarking to intervention: intentional vs unintentional behaviour
    12:00 Side effects, stockpiling and patients who stop without telling anyone
    13:00 Standard of care: bringing MMAS into EHR systems
    14:00 Zoe: the AI agent that has a conversation, not a checklist
    15:00 Pharmacist-led interventions and the Expert training programme
    17:00 Beyond medication: smoking, alcohol, exercise and diet derivatives
    19:00 Pharmacy refill data: access is not the same as adherence
    20:00 Partnerships and scaling across clinical and community settings
    21:00 The Kingdom of Bhutan and World Adherence Day
    22:00 Legacy: what his father started and what Philip is building
    24:00 The Checklist Manifesto — the book that defined structured adherence
    26:00 His sons: a merchant marine and a cybersecurity specialist
    27:00 Chief Optimist: Latin for the best
    29:00 Quick-fire: mess up early and often
    30:00 Curiosity, resilience and radical transparency
    32:00 Water polo, running with a Husky and living life
    33:00 Golden rule: adherence is the missing metric — let's fix it together

    👤 ABOUT PHILIP MORISKY

    Philip Morisky is Chief Optimist at Adherence, guardian of the Morisky Medication Adherence Scale (MMAS), and builder of Atlas, Zoe and the Expert pharmacist training programme.
    🌐 https://www.adherence.cc
    💼 Search "Philip Morisky" on LinkedIn

    🎙️ ABOUT PHARMA PRESCRIBED

    Long-form conversations with leaders in clinical research, digital health and mental wellbeing, hosted by Adam Walker.
    🌐 https://pharmaprescribed.com
    💼 https://www.linkedin.com/in/adam-walker-2327951/

    #PhilipMorisky #MMAS #MedicationAdherence #Adherence #PharmaPrescribed #AdamWalker #PatientAdherence #BehavioralScience #AtlasPlatform #ZoeAI #PharmacistIntervention #ClinicalTrials #DigitalHealth #LifeSciences #ChiefOptimist

    35 min
  • Building a Company While Your Country Is at War

    Yuriy Lebid on Building a CRO during Ukraine War & Never Giving Up | Pharma Prescribed

    Yuriy Lebid — CEO of Pharmaxi — joins Adam Walker for Episode 2 of the Pharma Prescribed Podcast, and one of the most extraordinary stories of entrepreneurial resilience in the entire series.

    Yuriy is a doctor, scientist and self-taught clinical research expert who built a full-service CRO from scratch in Ukraine. When Russia invaded on February 24th, 2022, he made a promise to his 28 employees: no one would be fired, salaries would be paid in full for six months, whatever happened. He made 90 calls in 30 days, relocated his team, restarted trials, expanded into Poland — and came out the other side stronger.

    Pharmaxi just celebrated its 10th anniversary.

    🎧 LISTEN ON YOUR PREFERRED APP

    Spotify → https://open.spotify.com/episode/4G7L6P4qMxZghoa0cTVx7u?si=KBa6XG-jTriJv9ixjKgggA
    Apple Podcasts → https://podcasts.apple.com/gb/podcast/pharma-prescribed-podcast-with-yuriy-lebid-ceo/id1829715970?i=1000719645727
    Amazon Music → https://music.amazon.com/podcasts/1a43eb87-b83e-441d-9a87-321263e3f821/adam-walker%E2%80%99s-pharma-prescribed-podcast
    Podbean → https://www.podbean.com/eas/pb-decmi-191ab66

    📖 WHAT WE COVER

    - Building a CRO from scratch in Ukraine with no portfolio and no clients
    - The promise on day one of the invasion: no one fired, full salaries for six months
    - 90 calls in 30 days — finding work while his country was being invaded
    - Enrollment rates higher during the war than before — and why
    - Expanding into Poland: 30% of the team now there, 40% of new projects
    - Travel restrictions: men aged 18–60 cannot leave Ukraine without permission
    - "Home is our castle" — productivity, stress and the power of rootedness
    - What disaster recovery actually looks like when you've lived through it
    - Conference speaking: teaching companies to build resilience before crisis hits
    - Passion first, money will find you — the golden rule
    - Tennis, fresh minds and forehand down the line

    ⏱️ CHAPTERS

    0:00 Introduction & podcast mission
    1:00 Meet Yuriy Lebid — CEO of Pharmaxi
    2:00 Medical university to science to clinical research — not a straight line
    3:00 Self-education in clinical research: from protocol to final report
    4:00 Building a CRO with no portfolio — "just trust our eyes"
    5:00 10th anniversary: the milestone that almost didn't happen
    6:00 February 24th, 2022 — the invasion begins
    7:00 Russian tanks in Kyiv and the pain of a threatened entrepreneur
    8:00 The promise: no firings, full salaries, six months guaranteed
    9:00 Relocating 28 employees and their families
    10:00 Remote work under fire — phones, internet and travel restrictions
    11:00 90 calls in 30 days — finding contracts during invasion
    12:00 "Legs in the sand" — moving forward under impossible pressure
    13:00 Restarting trials: enrollment higher than before the war
    14:00 Canadian biotech and a device study completed in six months
    15:00 Expanding into Poland: regulatory differences and growth
    16:00 30% in Poland, 70% in Ukraine, growing fast
    17:00 Speaking at conferences on resilience and disaster recovery
    18:00 Building resilience before crisis — not during it
    19:00 Travel restrictions: special permission to cross the border
    20:00 "Country and motherland means a lot" — the biggest discovery
    21:00 Home as productivity: background stress vs rootedness
    22:00 10 years and looking forward to growth
    23:00 Ukraine as a fruitful space for clinical trials right now
    24:00 Most famous Ukrainian CRO — one name, everyone knows it
    26:00 Quick-fire: think about opportunities, not fears
    27:00 Honesty, fire in the eyes and continuous learning
    29:00 Tennis: forehand down the line and a fresh mind
    30:00 Golden rule: passion first — money will find you
    31:00 Daughter Irina and passing on the principle
    32:00 LinkedIn and the beauty of this industry
    33:00 Closing thanks

    👤 ABOUT YURIY LEBID

    CEO of Pharmaxi, a full-service CRO covering Ukraine and Poland. Doctor, scientist, self-taught clinical research expert. Conference speaker on entrepreneurial resilience.
    💼 Search "Yuriy Lebid" on LinkedIn

    🎙️ ABOUT PHARMA PRESCRIBED

    Long-form conversations with leaders in clinical research, digital health and mental wellbeing, hosted by Adam Walker.
    🌐 https://pharmaprescribed.com
    💼 https://www.linkedin.com/in/adam-walker-2327951/

    #YuriyLebid #Pharmaxi #Ukraine #ClinicalTrials #PharmaPrescribed #AdamWalker #CROUkraine #Resilience #WarAndResearch #PolandClinicalTrials #Entrepreneurship #LifeSciences #DisasterRecovery #ClinicalResearch #PassionFirst

    34 min
  • He Qualified Through Lebanon's Collapse. Now He Needs One Chance

    Charbel Abdo on Pharmacy in Lebanon, Resilience & Seeking His First Role in UK Clinical Research | Pharma Prescribed

    Charbel Abdo — pharmacist from Lebanon, MSc Pharmaceutical Sciences (distinction) from the University of Greenwich — joins Adam Walker for one of the most personal and hopeful conversations on the Pharma Prescribed Podcast.

    Charbel grew up in a small village in Lebanon, moved to Beirut alone to study pharmacy, graduated during the country's worst economic crisis, then came to the UK to earn his Master's. He and Adam met by accident — Charbel was showing a stranger to a room at Greenwich and walked into an AstraZeneca networking event. That stranger was Adam.

    He's now actively seeking his first role in clinical research in the UK. This episode is his platform.

    🎧 LISTEN ON YOUR PREFERRED APP

    Spotify → https://open.spotify.com/episode/44h2ahvetwDFZCNfVCbrw0?si=CMoWG-sLToKIw1FIea9Bhg
    Apple Podcasts → https://podcasts.apple.com/gb/podcast/pharma-prescribed-podcast-with-charbel-abdo-the-human/id1829715970?i=1000719645703
    Amazon Music → https://music.amazon.com/podcasts/1a43eb87-b83e-441d-9a87-321263e3f821/adam-walker%E2%80%99s-pharma-prescribed-podcast
    Podbean → https://www.podbean.com/eas/pb-4kqqk-191aa56

    📖 WHAT WE COVER

    - Growing up in a small Lebanese village and moving to Beirut alone at 18
    - Pharmacy degree during Lebanon's economic collapse — salary worth nothing
    - MSc with distinction at the University of Greenwich
    - The accidental meeting: showing a stranger to a room and walking into AstraZeneca
    - The small world: Adam introduces Charbel to Wael — who turns out to know his family
    - Why the UK needs fully qualified pharmacists and isn't hiring them
    - Resilience, sacrifice and the deep strength behind every qualification
    - Cooking as a passion — pharmacology as cooking medication
    - Be honest — and if you do something, finish it properly

    ⏱️ CHAPTERS

    0:00 Introduction & podcast mission
    1:00 Meet Charbel Abdo — pharmacist from Lebanon
    2:00 How we met: a stranger, a room and an AstraZeneca event
    4:00 The Wael connection — one village, two continents, same family
    6:00 Why the UK needs pharmacists from abroad
    8:00 Pharmacy school in Beirut — GPA pressure and resilience
    12:00 Lebanon's economic crisis and graduating into collapse
    16:00 Moving to the UK and the Greenwich MSc
    20:00 Regulatory differences between Lebanon and the UK
    24:00 What clinical research means to Charbel
    28:00 Seeking his first role — and what he brings to the table
    32:00 Quick-fire: cooking, Heston Blumenthal and one day a restaurant
    34:00 Golden rule: be honest — and finish what you start
    36:00 Reach Charbel on LinkedIn — and closing thanks

    👤 ABOUT CHARBEL ABDO

    Pharmacist (Lebanon). MSc Pharmaceutical Sciences with distinction (University of Greenwich). Actively seeking his first role in UK clinical research.
    💼 Search "Charbel Abdo" on LinkedIn

    🎙️ ABOUT PHARMA PRESCRIBED

    Long-form conversations with leaders in clinical research, digital health and mental wellbeing, hosted by Adam Walker.
    🌐 https://pharmaprescribed.com
    💼 https://www.linkedin.com/in/adam-walker-2327951/

    #CharbelAbdo #Pharmacist #Lebanon #ClinicalResearch #PharmaPrescribed #AdamWalker #UniversityOfGreenwich #PharmaceuticalSciences #UKPharma #Resilience #NewToIndustry #LifeSciences #PharmacyCareer #Greenwich #HireMe

    37 min
  • The Medtech Outsider Telling Pharma What It Gets Wrong

    Matthew Mace on Study Connect, Why Pharma Needs MedTech Outsiders in Cardiology | Pharma Prescribed

    Matthew Mace — founder of Study Connect, host of the Study Success Podcast and board director at Precision Cardiovascular — joins Adam Walker for one of the most energetic conversations on the Pharma Prescribed Podcast.

    Matt isn't from pharma. He comes from MedTech, cardiovascular devices and cardiology innovation. As co-founder and CSO at Acharai, he led the largest hemodynamic study in heart failure history, secured FDA breakthrough device designation and raised over $10M. Now he's building Study Connect — a platform to streamline collaboration between investigators and sponsors — while serving on the board at Precision Cardiovascular.

    He also runs marathons, does Ironmans and never misses Saturday morning daddy-daughter time.

    🎧 LISTEN ON YOUR PREFERRED APP

    Spotify → https://open.spotify.com/episode/1GIdsiPgFjsykGyzFPPvRk?si=4erLYiySS8mgS80tVziGsQ
    Apple Podcasts → https://podcasts.apple.com/gb/podcast/pharma-prescribed-with-matthew-mace-founder-of/id1829715970?i=1000719640597
    Amazon Music → https://music.amazon.com/podcasts/1a43eb87-b83e-441d-9a87-321263e3f821/adam-walker%E2%80%99s-pharma-prescribed-podcast
    Podbean → https://www.podbean.com/eas/pb-su9t6-19186e9

    📖 WHAT WE COVER

    - MedTech outsider looking in: what pharma gets wrong about collaboration
    - The largest hemodynamic study in heart failure history
    - FDA breakthrough device designation and raising $10M
    - Study Connect: beta testing the platform with physicians
    - Why investigators don't want another portal — they want connection
    - The Study Success Podcast and why Matt started it
    - Marathons, Ironman and the 85-year-old doing all seven majors
    - Saturday morning daddy-daughter time at the play park
    - Do the right thing, be honest — the golden rule

    ⏱️ CHAPTERS

    0:00 Introduction & podcast mission
    1:00 Meet Matthew Mace — founder of Study Connect
    2:00 "I come with a warning — I'm non-pharma pretending I know about trials"
    3:00 Study Connect beta launch and physician feedback
    5:00 15 years in cardiology, AI and MedTech
    8:00 Acorai: the largest hemodynamic study in heart failure
    12:00 FDA breakthrough device and raising $10M
    16:00 Study Connect: what the platform actually does
    20:00 Universal problems across CROs, sponsors and tech companies
    24:00 Why investigators need connection, not another portal
    28:00 Precision Cardiovascular and next-gen monitoring
    32:00 Marathons, Ironman and the grandfather who ran for GB
    36:00 Saturday mornings, Asa and daddy-daughter time
    38:00 Quick-fire: honesty and doing the right thing
    40:00 studyconnect.world — and the chatbot that goes straight to Matt's inbox

    👤 ABOUT MATTHEW MACE

    Founder of Study Connect. Host of the Study Success Podcast. Board director at Precision Cardiovascular. Former CSO at Acharai. 15+ years in cardiology, AI and MedTech.
    🌐 https://www.studyconnect.world
    💼 Search "Matthew Mace" on LinkedIn

    🎙️ ABOUT PHARMA PRESCRIBED

    Long-form conversations with leaders in clinical research, digital health and mental wellbeing, hosted by Adam Walker.
    🌐 https://pharmaprescribed.com
    💼 https://www.linkedin.com/in/adam-walker-2327951/

    #MatthewMace #StudyConnect #StudySuccessPodcast #PrecisionCardiovascular #PharmaPrescribed #AdamWalker #MedTech #Cardiology #HeartFailure #FDABreakthrough #ClinicalTrials #LifeSciences #Ironman #Marathon #InvestigatorEngagement

    42 min
  • 25 Years Assessing the World's Trial Units — and the Consultants Nobody Can See

    Charlotte Chadwick on Clinology, 25 Years in Clinical & Consultant Visibility | Pharma Prescribed

    Charlotte Chadwick — founder of Clinology and Dynamic Clinical Solutions — joins Adam Walker for a conversation about 25 years in clinical operations, building a phase one unit from scratch and creating a platform that makes expert consultants visible to the companies that need them.

    Charlotte started as a junior QC at a generic trial site in Manchester, became a CRA at Lundbeck, spent 13 years assessing 80–90% of the world's phase one units, built the Early Phase Unit at MAC Clinical Research (a name she coined and wishes she'd trademarked), rose to VP of Clinical Operations, then became COO at Zigzag Associates — a global QA consultancy. Now she runs two businesses: Dynamic Clinical Solutions for full-time consulting and Clinology to connect independent consultants with pharma clients directly.

    Adam and Charlotte first worked together at MAC Clinical in Manchester.

    🎧 LISTEN ON YOUR PREFERRED APP

    Spotify → https://open.spotify.com/episode/7nrR1DkzXrYN4sk0zEDYet?si=lGnplu-cQPmLNSZsoKGjfQ
    Apple Podcasts → https://podcasts.apple.com/gb/podcast/pharma-prescribed-podcast-with-charlotte-chadwick-ceo/id1829715970?i=1000719640731
    Amazon Music → https://music.amazon.com/podcasts/1a43eb87-b83e-441d-9a87-321263e3f821/adam-walker%E2%80%99s-pharma-prescribed-podcast
    Podbean → https://www.podbean.com/eas/pb-r3isw-18f513a

    📖 WHAT WE COVER

    - So You Want to be a CRA — the book that started everything
    - 13 years at Lundbeck assessing phase one units across the world
    - Building the EPU at MAC Clinical Research from bare hands
    - Three MHRA accreditations with no major findings
    - Zigzag Associates: learning C-suite and global QA auditing
    - Why consultants are invisible — and how Clinology fixes that
    - Fiverr for clinical research: the business model explained
    - Credits not commissions: no middlemen, no contract interference
    - The parallel between her career and Adam's at MAC
    - Don't overthink it — just start

    ⏱️ CHAPTERS

    0:00 Introduction & podcast mission
    1:00 Meet Charlotte Chadwick — founder of Clinology
    2:00 So You Want to be a CRA — the book that started it all
    3:00 Junior QC at Shain Clinic Manchester
    4:00 13 years at Lundbeck: 80–90% of the world's phase one units
    5:00 Building the EPU at MAC Clinical Research
    7:00 VP Clinical Operations and the SMO network
    8:00 Zigzag QA consultancy and learning C-suite
    9:00 Going independent: two businesses in 12 months
    10:00 Why Clinology exists — making consultants visible
    12:00 The business model: credits not commissions
    14:00 Five weeks live and early traction
    16:00 AI, fractional consulting and the future of clinical ops
    18:00 Quick-fire and golden rule

    👤 ABOUT CHARLOTTE CHADWICK

    Founder of Clinology and Dynamic Clinical Solutions. 25+ years in clinical operations. Former VP at MAC Clinical Research and COO at Zigzag Associates.
    🌐 https://www.clinology.co.uk
    💼 Search "Charlotte Chadwick" on LinkedIn

    🎙️ ABOUT PHARMA PRESCRIBED

    Long-form conversations with leaders in clinical research, digital health and mental wellbeing, hosted by Adam Walker.
    🌐 https://pharmaprescribed.com
    💼 https://www.linkedin.com/in/adam-walker-2327951/

    #CharlotteChadwick #Clinology #ClinicalOperations #PhaseOne #PharmaPrescribed #AdamWalker #MACClinical #Lundbeck #ClinicalConsulting #EPU #QualityAssurance #LifeSciences #ClinicalResearch #FemaleFounder #IndependentConsultant

    49 min

About Adam Walker’s Pharma Prescribed Podcast

From the publisher's feed

Get ready for open and honest long-form conversations with fascinating and passionate individuals in clinical research.
These are people you may or may not be aware of, with one thing in common -…